Lead lawyer for state and federal legislation and Congressional investigations for America's largest digital asset exchange.

Provided legal and strategic counsel on a variety of competition, technology, intellectual property, diversity, and economic inequality issues. Evaluated issues to determine policy objectives, drafted legislation, managed outside lobbying and communications firms, and directly advocated for industry legislative and regulatory priorities. Built narratives to support policy objectives by developing communications strategies, coalitions, third party validators, and written materials.

Developed policy, communications, and litigation strategies surrounding the highest priority issues of a national trade association. Researched and developed policy positions on payments and technology policy, mortgage regulations, government sponsored enterprises, capital requirements, and administrative law. Advocated for these positions before Congress, regulators (CFPB, FHFA, NCUA, Treasury, GAO), courts, reporters, coalitions, and association members. Appointed to association’s Management Team.

Served in roles of increasing complexity and responsibility across all aspects of antitrust and commercial litigation practice. Mastered legal analysis, counseling clients, using evidence to build the client’s narrative, writing about complex legal issues in layman’s terms, preparing clients for depositions and interviews, breaking difficult issues into specific decision points, and managing teams. Worked with multiple clients to develop antitrust compliance programs, and provide practical legal advice without taking unnecessary risks. Representative experience includes: • Defended Georgia hospital in FTC investigation, as well as district court and appellate litigation, related to acquisition of a competitor in a case ultimately decided by the U.S. Supreme Court. • Defended major private equity firm in class action against leading private equity firms and investment banks. • Represented leading textbook publisher in regulatory review by DOJ and state Attorneys General in acquisition of major competitor. • Counseled major bio-pharmaceutical company on antitrust considerations in proposed spin-off of division. • Represented national retailer in investigation by FBI and U.S. Attorney into potential accounting fraud.